For the first time, mycobacteria from mice and melanoma patients were shown to play a pivotal role in immune stimulation of CTLA-4 blockade, with the antitumor effects of CTLA-4 blockade dependent on different mycobacterial species [91]. This evidence concerns the gene CTLA4 and melanoma.